Literature DB >> 32526354

The unique immune microenvironment of liver metastases: Challenges and opportunities.

Aaron T Ciner1, Keaton Jones2, Ruth J Muschel3, Pnina Brodt4.   

Abstract

Liver metastases from gastrointestinal and non-gastrointestinal malignancies remain a major cause of cancer-related mortality and a major clinical challenge. The liver has unique properties that facilitate metastatic expansion, including a complex immune system that evolved to dampen immunity to neoantigens entering the liver from the gut, through the portal circulation. In this review, we describe the unique microenvironment encountered by cancer cells in the liver, focusing on elements of the innate and adaptive immune response that can act as a double-edge sword, contributing to the elimination of cancer cells on the one hand and promoting their survival and growth, on the other. We discuss this microenvironment in a clinical context, particularly for colorectal carcinoma, and highlight how a better understanding of the role of the microenvironment has spurred an intense effort to develop novel and innovative strategies for targeting liver metastatic disease, some of which are currently being tested in the clinic.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Clinical trials; Immune cells; Immune tolerance; Liver metastasis; Microenvironment; Therapeutic targets

Mesh:

Year:  2020        PMID: 32526354     DOI: 10.1016/j.semcancer.2020.06.003

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  8 in total

Review 1.  Liver metastases.

Authors:  Diamantis I Tsilimigras; Pnina Brodt; Pierre-Alain Clavien; Ruth J Muschel; Michael I D'Angelica; Itaru Endo; Rowan W Parks; Majella Doyle; Eduardo de Santibañes; Timothy M Pawlik
Journal:  Nat Rev Dis Primers       Date:  2021-04-15       Impact factor: 52.329

Review 2.  Histopathological growth patterns of liver metastasis: updated consensus guidelines for pattern scoring, perspectives and recent mechanistic insights.

Authors:  Emily Latacz; Diederik Höppener; Ali Bohlok; Vincent Donckier; Peter M Siegel; Raymond Barnhill; Marco Gerling; Cornelis Verhoef; Peter B Vermeulen; Sophia Leduc; Sébastien Tabariès; Carlos Fernández Moro; Claire Lugassy; Hanna Nyström; Béla Bozóky; Giuseppe Floris; Natalie Geyer; Pnina Brodt; Laura Llado; Laura Van Mileghem; Maxim De Schepper; Ali W Majeed; Anthoula Lazaris; Piet Dirix; Qianni Zhang; Stéphanie K Petrillo; Sophie Vankerckhove; Ines Joye; Yannick Meyer; Alexander Gregorieff; Nuria Ruiz Roig; Fernando Vidal-Vanaclocha; Larsimont Denis; Rui Caetano Oliveira; Peter Metrakos; Dirk J Grünhagen; Iris D Nagtegaal; David G Mollevi; William R Jarnagin; Michael I D'Angelica; Andrew R Reynolds; Michail Doukas; Christine Desmedt; Luc Dirix
Journal:  Br J Cancer       Date:  2022-06-01       Impact factor: 9.075

3.  Interferon-γ increases sensitivity to chemotherapy and provides immunotherapy targets in models of metastatic castration-resistant prostate cancer.

Authors:  Dimitrios Korentzelos; Alan Wells; Amanda M Clark
Journal:  Sci Rep       Date:  2022-04-22       Impact factor: 4.996

Review 4.  The immunological and metabolic landscape in primary and metastatic liver cancer.

Authors:  Xin Li; Pierluigi Ramadori; Dominik Pfister; Marco Seehawer; Lars Zender; Mathias Heikenwalder
Journal:  Nat Rev Cancer       Date:  2021-07-29       Impact factor: 60.716

Review 5.  The Tumor Microenvironment in Liver Metastases from Colorectal Carcinoma in the Context of the Histologic Growth Patterns.

Authors:  Gemma Garcia-Vicién; Artur Mezheyeuski; María Bañuls; Núria Ruiz-Roig; David G Molleví
Journal:  Int J Mol Sci       Date:  2021-02-03       Impact factor: 5.923

6.  Prognostic significance and therapeutic potential of the immune checkpoint VISTA in pancreatic cancer.

Authors:  Zelin Hou; Yu Pan; Qinglin Fei; Yali Lin; Yuanyuan Zhou; Ying Liu; Hongdan Guan; Xunbin Yu; Xianchao Lin; Fengchun Lu; Heguang Huang
Journal:  J Cancer Res Clin Oncol       Date:  2020-11-25       Impact factor: 4.553

7.  Immunosuppressive landscape in hepatocellular carcinoma revealed by single-cell sequencing.

Authors:  Yi Bai; Dapeng Chen; Chuanliang Cheng; Zhongmin Li; Hao Chi; Yuliang Zhang; Xiaoyu Zhang; Shaohai Tang; Qiang Zhao; Bing Ang; Yamin Zhang
Journal:  Front Immunol       Date:  2022-07-28       Impact factor: 8.786

Review 8.  Liver Immune Microenvironment and Metastasis from Colorectal Cancer-Pathogenesis and Therapeutic Perspectives.

Authors:  Xuezhen Zeng; Simon E Ward; Jingying Zhou; Alfred S L Cheng
Journal:  Cancers (Basel)       Date:  2021-05-17       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.